Calliditas Therapeutics

Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.

Source: https://www.calliditas.se

budesonideTarpeyo

targeted-release corticosteroid

Tarpeyo (nefecon) is a targeted-release capsule of budesonide from Calliditas Therapeutics for adults with primary immunoglobulin A nephropathy (IgAN). It releases budesonide in the ileum to act on mucosal immunity. In the European Union the same medicine is authorised as Kinpeygo.

Nefecon is a capsule taken once daily that releases budesonide, a corticosteroid, in the ileum, the last part of the small intestine. There it calms t

1 medicine explained